Article PubMed
The Journal of rheumatology  (2005)

Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis.

Mavropoulos, John C; Cuchacovich, Miguel; Llanos, Carolina; Aguillón, Juan C; Gatica, Hector; Pizzo, Salvatore V; Gonzalez-Gronow, Mario